JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer

Paschalis, A; Welti, J; Neeb, AJ; Yuan, W; Figueiredo, I; Pereira, R; Ferreira, A; Riisnaes, R; Rodrigues, DN; Jimenez-Vacas, JM; Kim, S; Uo, T; Di Micco, P; Tumber, A; Islam, MS; Moesser, MA; Abboud, M; Kawamura, A; Gurel, B; Christova, R; Gil, VS; Buroni, L; Crespo, M; Miranda, S; Lambros, MB; Carreira, S; Tunariu, N; Alimonti, A; Al-Lazikani, B; Schofield, CJ; Plymate, SR; Sharp, A; de Bono, JS

View/Open

Published version (1.689Mb)

Date

2021-02-15

ICR Author

Author

Paschalis, A

Welti, J

Neeb, AJ

Yuan, W

Figueiredo, I

Show all

Type

Journal Article

Subject

Science & Technology

Life Sciences & Biomedicine

Oncology

ANDROGEN-RECEPTOR

INCREASED SURVIVAL

GENE

PROTEIN

PROGRESSION

ABIRATERONE

VALIDATION

INHIBITORS

INTERACTS

ONTOLOGY

Research team

Computational Biology and Chemogenomics

Cancer Biomarkers

Prostate Cancer Targeted Therapy Group

Computational Biology and Chemogenomics

Cancer Biomarkers

Prostate Cancer Targeted Therapy Group

Language

eng

Date accepted

2020-12-02

License start date

2021-02-15

Citation

CANCER RESEARCH, 2021, 81 (4), pp. 1087 - 1100 (14)

Publisher

AMER ASSOC CANCER RESEARCH

Publications Repository

Publications Repository